Brendan Lo (13) receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19) at Northwell Health's Cohen Children's Medical Center in New Hyde Park, New York, U.S., May 13, 2021. REUTERS/Shannon StapletonRegister now for FREE unlimited access to Reuters.comJan 3 (Reuters) - The U.S. Food and Drug Administration has authorized the use of…
The U.S. Food and Drug Administration has authorized the use of a third dose of the Pfizer (PFE.N) and BioNTech COVID-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots by a month to five months after the primary doses.
The agency on Monday also authorized a third shot in children aged 5 through 11 years who are immunocompromised.
The regulatory decisions come as COVID-19 cases surge due to the Omicron variant, with health authorities warning that its high transmissibility could overwhelm many health systems.
Read Full Story
Reuters Rating
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
